MedPath

Improvement in pain and function through analgesic and anti-inflammatory radiotherapy in patients with finger arthritis, medial/lateral epicondylitis or plantar fasciitis

Not Applicable
Recruiting
Conditions
plantar fasciitis, epicondylitis, polyarthritis of the finger joints
M15.9
M19.9
M18
M76
M77.0
M77.5
M77.1
Polyarthrosis, unspecified
Arthrosis, unspecified
Registration Number
DRKS00006288
Lead Sponsor
Kantonsspital AarauZentrum für Radio-Onkologie KSA-KSB
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

Age over 40 year, Karnofsky Index at least 70%, Patients cannot be pregnant, Patients of child bearing age must use a medically acceptable form of contraception during the radiotherapy as well as 12 months after, Patients cannot have any congenital disease with increased sensitivity to radiation, absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial, before patient registration/randomization, written informed consent must be given according to ICH/GCP, and national/local regulations, patients will have been treated with conventional therapeutic interventions for at least 6 months

Exclusion Criteria

congenital disease with increased sensitivity to radiation, psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain will be assessed using the Visual Analog Scale. Musculoskeletal function will be documented using a dynamometer for patients with hand and elbow disorders and a walking test will be performed for patients with plantar fasciitis. The HAQ (health assessment) and EQ-5D (quality of life) questionnaires will be completed by all patients. Assessments will be performed at baseline and at 2, 6 and 12 months after radiotherapy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath